Intraoperative Dexmedetomidine and Coronary Artery Bypass Graft Surgery - Trial NCT06378827
Access comprehensive clinical trial information for NCT06378827 through Pure Global AI's free database. This Phase 2/3 trial is sponsored by University of Novi Sad and is currently Recruiting. The study focuses on Acute Kidney Injury. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Novi Sad
Timeline & Enrollment
Phase 2/3
Apr 03, 2024
Oct 01, 2024
Primary Outcome
Indicator of renal function,An early biomarker of kidney injury,The change of inflammatory markers
Summary
This is a prospective randomized clinical trial designed to determine the effect of
 intraoperative dexmedetomidine administration on renal function after coronary artery bypass
 graft surgery.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06378827
Non-Device Trial